Heparin Market Size to Grow by USD 2.29 billion, 37% of Market Growth to Originate from Europe

NEW YORK, July 27, 2022 /PRNewswire/ — Heparin is an anticoagulant that prevents the formation of blood clots. It is used for the prevention and treatment of thrombotic events, such as deep vein thrombosis and pulmonary embolism, as well as atrial fibrillation. It is also used to prevent excess coagulation during procedures such as extracorporeal circulation and cardiac surgery replacement therapy.

Technavio has announced its latest market research report titled Heparin Market by Product, Route of Administration, and Geography - Forecast and Analysis 2021-2025

Technavio has announced its latest market research report titled Heparin Market by Product, Route of Administration, and Geography – Forecast and Analysis 2021-2025

The heparin market size is expected to grow by USD 2.29 bn from 2020 to 2025. In addition, the growth momentum of the market will accelerate at a CAGR of 6.06% during the forecast period.

Get a comprehensive report summary describing the heparin market size and forecast along with research methodology. the sample report is available in PDF format

Heparin Market 2021-2025: Scope

The heparin market report covers the following areas:

Get lifetime access to our Technavio Insights! Subscribe to our “Basic Plan” billed annually at $5000

Heparin Market 2021-2025: Driver and Challenge

the increasing prevalence of coagulation disorders is driving the growth of the heparin market. Some of the common coagulation disorders include Von Willebrand disease, hemophilia, deep venous thrombosis, hypercoagulable states, and clotting factor deficiencies. The increasing prevalence of these coagulation disorders needs continuous monitoring for further medical interventions. Furthermore, physicians recommend coagulation tests during major surgeries.

the side effects of heparin wants to challenge the growth of the heparin market. Bleeding is the main side effect of heparin. Other adverse effects include heparin-induced thrombocytopenia, heparin-associated osteoporosis, skin reactions, eosinophilia, and allergic reactions. Among these, heparin-induced thrombocytopenia and osteoporosis are the most common. Hence, the use of heparin is decreasing due to its side effects. Moreover, the increasing awareness about the side effects of heparin will hamper the growth of the global heparin market.

Heparin Market 2021-2025: Segmentation

Heparin Market 2021-2025: Key Highlights

  • CAGR of the market during the forecast period 2021-2025

  • Detailed information on factors that will assist heparin market growth during the next five years

  • Estimation of the heparin market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the heparin market

  • Analysis of the market’s competitive landscape and detailed information on vendors

  • Comprehensive details of factors that will challenge the growth of the heparin market vendors

Related Reports

Venous Blood Collection Market by Application and Geography – Forecast and Analysis 2022-2026

Hairy Cell Leukemia Therapeutics Market by Product and Geography – Forecast and Analysis 2022-2026

Heparin Market Scope

report coverage


Page number


base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 6.06%

Market growth 2021-2025

USD 2.29 billion

Market structure


YoY growth (%)


Regional analysis

Europe, North America, Asia, and ROW

Performing market contribution

Europe at 37%

Key consumer countries

US, UK, Germany, China, and France

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Aspen Pharmacare Holdings Ltd., Baxter International Inc., Eisai Co. Ltd., Fresenius SE and Co. KGaA, Hikma Pharmaceuticals Plc, Laboratorios Farmaceuticos Rovi SA, Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, and Viatris Inc.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get customized segments.

Table of Contents:

1 executive summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Market segmentation by route of administration

7 customer landscape

8 Geographic Landscape

9 Drivers, Challenges, and Trends

10 Vendor Landscape

11 Vendor analysis

12 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Technavio (PRNews photo/Technavio)

Technavio (PRNews photo/Technavio)



View original content to download multimedia:https://www.prnewswire.com/news-releases/heparin-market-size-to-grow-by-usd-2-29-billion-37-of-market-growth-to -originate-from-europe—technavio-301593545.html

SOURCE Technavio

Leave a Comment